Author:
Vanheer Leen N.,Mahamar Almahamoudou,Manko Emilia,Niambele Sidi M.,Sanogo Koualy,Youssouf Ahamadou,Dembele Adama,Diallo Makonon,Maguiraga Seydina O.,Phelan Jody,Osborne Ashley,Spadar Anton,Smit Merel J.,Bousema Teun,Drakeley Chris,Clark Taane G.,Stone William,Dicko Alassane,Campino Susana
Abstract
AbstractSequence analysis of Plasmodium falciparum parasites is informative in ensuring sustained success of malaria control programmes. Whole-genome sequencing technologies provide insights into the epidemiology and genome-wide variation of P. falciparum populations and can characterise geographical as well as temporal changes. This is particularly important to monitor the emergence and spread of drug resistant P. falciparum parasites which is threatening malaria control programmes world-wide. Here, we provide a detailed characterisation of genome-wide genetic variation and drug resistance profiles in asymptomatic individuals in South-Western Mali, where malaria transmission is intense and seasonal, and case numbers have recently increased. Samples collected from Ouélessébougou, Mali (2019–2020; n = 87) were sequenced and placed in the context of older Malian (2007–2017; n = 876) and African-wide (n = 711) P. falciparum isolates. Our analysis revealed high multiclonality and low relatedness between isolates, in addition to increased frequencies of molecular markers for sulfadoxine-pyrimethamine and lumefantrine resistance, compared to older Malian isolates. Furthermore, 21 genes under selective pressure were identified, including a transmission-blocking vaccine candidate (pfCelTOS) and an erythrocyte invasion locus (pfdblmsp2). Overall, our work provides the most recent assessment of P. falciparum genetic diversity in Mali, a country with the second highest burden of malaria in West Africa, thereby informing malaria control activities.
Funder
Biotechnology and Biological Sciences Research Council
Bill and Melinda Gates Foundation
Medical Research Council
Publisher
Springer Science and Business Media LLC
Reference54 articles.
1. World Health Organization, World malaria report 2022. Geneva: World Health Organization, 2022. Accessed: Dec. 18, 2022. [Online]. Available: https://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2022
2. Cissoko, M. et al. Geo-epidemiology of malaria at the health area level, dire health District, Mali, 2013–2017. Int. J. Environ. Res. Public. Health 17(11), 3982. https://doi.org/10.3390/ijerph17113982 (2020).
3. Dhorda, M., Amaratunga, C. & Dondorp, A. M. Artemisinin and multidrug-resistant Plasmodium falciparum—A threat for malaria control and elimination. Curr. Opin. Infect. Dis. 34(5), 432. https://doi.org/10.1097/QCO.0000000000000766 (2021).
4. Sirawaraporn, W., Sathitkul, T., Sirawaraporn, R., Yuthavong, Y. & Santi, D. V. Antifolate-resistant mutants of Plasmodium falciparum dihydrofolate reductase. Proc. Natl. Acad. Sci. U.S.A. 94(4), 1124–1129. https://doi.org/10.1073/pnas.94.4.1124 (1997).
5. Staedke, S. G. et al. Relationship between age, molecular markers, and response to sulphadoxine–pyrimethamine treatment in Kampala, Uganda. Trop. Med. Int. Health 9(5), 624–629. https://doi.org/10.1111/j.1365-3156.2004.01239.x (2004).